Brief: Peptonic Medical Q3 Sales at SEK 9.525 Million
24/10/2023 07:33
Oct 24 (Reuters) - Peptonic Medical Q3 operating profit SEK 9.917 million. * Q3 sales SEK 9.525 million * Q3 gross margin 47% * Q3 gross profit SEK 4.517 million * Q3 EPS SEK -0.01
Recent news on Peptonic Medical AB
See all newsSweden's Peptonic Medical Q2 sales drop, gross margin narrows
Brief: Peptonic Medical Q2 Sales SEK 2.36 Million
Sweden's Peptonic Medical Q1 operating loss narrows on restructuring
Brief: Peptonic Medical Q1 Sales SEK 3.138 Million
Sweden's Peptonic Medical Q4 sales fall, margin improves on restructuring efforts